IVM
InterWest Venture Management Portfolio holdings
AUM
$20.6M
This Quarter Return
+15.86%
1 Year Return
+48.5%
3 Year Return
-59.65%
5 Year Return
-75.84%
10 Year Return
–
AUM
$419M
AUM Growth
–
Cap. Flow
+$419M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
98.59%
Holding
14
New
14
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$272M |
| 2 |
Glaukos
GKOS
|
$34.9M |
| 3 |
MacroGenics
MGNX
|
$22M |
| 4 |
HIND
Vyome Holdings, Inc. Common Stock
HIND
|
$21.7M |
| 5 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$18.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
1
DELISTED
TESARO, Inc.
TSRO
| $272M | 64.82% |
+2,021,403
| New | +$272M |
|
|
2
Glaukos
GKOS
$5.5B
| $34.9M | 8.33% |
+1,018,362
| New | +$34.9M |
|
|
3
MacroGenics
MGNX
$112M
| $22M | 5.24% |
+1,074,316
| New | +$22M |
|
|
HIND
4
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $21.7M | 5.18% |
+2,453,338
| New | +$21.7M |
|
|
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $18.6M | 4.44% |
+1,599,592
| New | +$18.6M |
|
6
Cidara Therapeutics
CDTX
$1.66B
| $14.1M | 3.36% |
+1,356,813
| New | +$14.1M |
|
|
AGTC
7
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $13.6M | 3.24% |
+1,452,216
| New | +$13.6M |
|
|
PRTK
8
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $7.89M | 1.88% |
+512,366
| New | +$7.89M |
|
|
IVTY
9
DELISTED
Invuity, Inc
IVTY
| $6.21M | 1.48% |
+1,080,272
| New | +$6.21M |
|
|
OCRX
10
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $2.62M | 0.62% |
+1,248,064
| New | +$2.62M |
|
11
Xenon Pharmaceuticals
XENE
$2.98B
| $2.47M | 0.59% |
+320,061
| New | +$2.47M |
|
12
KalVista Pharmaceuticals
KALV
$678M
| $2.33M | 0.56% |
+329,942
| New | +$2.33M |
|
13
MEI Pharma
MEIP
$160M
| $836K | 0.2% |
+580,401
| New | +$836K |
|
|
RETA
14
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $285K | 0.07% |
+13,058
| New | +$285K |
|